Investor centre
ASX Announcements
2026
01 Sep 2026
1:50pm
Section 708A Cleansing Statement
Cleansing Notice
01 Sep 2026
1:48pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
01 Sep 2026
1:04pm
Change of Director's Interest Notice - DW
Change of Director's Interest Notice
26 Aug 2026
10:06am
Appendix 4G and Corporate Governance Statement
Corporate Governance
Takeover - Appendix 4G
26 Aug 2026
9:44am
Market sensitive
FY26 Full Year Results Announcement
Preliminary Final Report
Periodic Reports - Other
26 Aug 2026
9:41am
FY26 Annual Report
Annual Report
Top 20 shareholders
Full Year Accounts
Full Year Audit Review
Full Year Directors' Statement
Full Year Directors' Report
26 Aug 2026
9:22am
Market sensitive
FY26 Appendix 4E
Preliminary Final Report
07 Aug 2026
11:02am
Lumos to Present at 20th Bioshares Biotech Summit
Company Presentation
04 Aug 2026
9:04am
Market sensitive
Lumos Receives FebriDx Order from PHASE Scientific
Progress Report
30 Jul 2026
9:38am
Lumos Secures Distribution for FebriDx in Romania
Progress Report
28 Jul 2026
12:42pm
Change of Director's Interest Notice - DW
Change of Director's Interest Notice
28 Jul 2026
9:40am
Section 708A Cleansing Statement
Cleansing Notice
28 Jul 2026
9:37am
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
27 Jul 2026
12:01pm
Investor Presentation
Company Presentation
Web Casts
27 Jul 2026
9:55am
Market sensitive
Quarterly Activities/Appendix 4C Cash Flow Report
Web Casts
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
21 Jul 2026
12:08pm
Market sensitive
FebriDx Commercial Traction Across Priority US Accounts
Progress Report
20 Jul 2026
11:01am
Q4 FY26 Results Release Date and Webinar Invitation
Notification of Results/Reporting Date
20 Jul 2026
10:50am
Investor Information Sessions
Company Administration - Other
14 Jul 2026
1:06pm
Notification of cessation of securities - LDX
Appendix 3H (Notification of cessation of securities)
02 Jul 2026
2:27pm
Closure of A$5M Loan Facility with Major Shareholders
Debt Facility
29 Jun 2026
9:54am
Market sensitive
Lumos Receives Research & Development Tax Rebate
Periodic Reports - Other
25 Jun 2026
11:48am
Change of Director's Interest Notice - SL
Change of Director's Interest Notice
22 Jun 2026
12:12pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
19 Jun 2026
9:13am
Change of Director's Interest Notice - CR
Change of Director's Interest Notice
11 Jun 2026
9:58am
Investor Presentation - FebriDx US Commercial Update
Company Presentation
05 Jun 2026
2:51pm
Change of Director's Interest Notice - DW
Change of Director's Interest Notice
04 Jun 2026
11:23am
FebriDx US Commercial Update Webinar Invitation
Web Casts
20 May 2026
1:24pm
Section 708A Cleansing Statement
Cleansing Notice
20 May 2026
1:24pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
18 May 2026
11:42am
Market sensitive
FebriDx U.S. Rollout and Reimbursement Update - Amended
Progress Report
18 May 2026
9:49am
Market sensitive
FebriDx U.S. Rollout and Reimbursement Update
Progress Report
14 May 2026
9:37am
Market sensitive
FebriDx Paediatric Study Enrolment Milestone Achieved
Progress Report
07 May 2026
2:02pm
Lumos receives US$0.5m CLIA waiver milestone payment
Periodic Reports - Other
01 May 2026
11:16am
Change of Director's Interest Notice - CR
Change of Director's Interest Notice
01 May 2026
11:16am
Change of Director's Interest Notice - SL
Change of Director's Interest Notice
01 May 2026
11:11am
Notification regarding unquoted securities - LDX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
01 May 2026
11:10am
Notification regarding unquoted securities - LDX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
01 May 2026
11:08am
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
01 May 2026
11:04am
Results of Share Purchase Plan
Security Purchase Plan
30 Apr 2026
4:23pm
Change of Director's Interest Notice - SL
Change of Director's Interest Notice
21 Apr 2026
10:32am
Q3 FY26 Results Investor Presentation
Company Presentation
Commitments Test Entity - Third Quarter Report
20 Apr 2026
9:49am
Market sensitive
Quarterly Activities/Appendix 4C Cash Flow Report
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
16 Apr 2026
9:33am
Notification of cessation of securities - LDX
Appendix 3H (Notification of cessation of securities)
15 Apr 2026
4:26pm
Lumos Q3 FY26 Results Webinar Invitation
Security Purchase Plan
Web Casts
Notification of Results/Reporting Date
14 Apr 2026
2:35pm
Lumos expands WellStreet Urgent Care locations
Progress Report
14 Apr 2026
10:14am
Change in substantial holding from RYD
Change in substantial holding
14 Apr 2026
9:13am
Lumos receives US$5m FebriDx milestone payment from PHASE
Progress Report
10 Apr 2026
5:31pm
Market sensitive
Response to ASX Aware Letter
Response to ASX Query
10 Apr 2026
9:32am
Target Market Determination
Other
10 Apr 2026
9:31am
Market sensitive
Prospectus
Disclosure Document
10 Apr 2026
9:30am
SPP - Letter to Eligible Shareholders
Security Purchase Plan
Letter to Shareholders
09 Apr 2026
12:10pm
Section 708A Cleansing Statement
Cleansing Notice
09 Apr 2026
12:10pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
09 Apr 2026
12:06pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
09 Apr 2026
12:05pm
Section 708A Cleansing Statement
Cleansing Notice
08 Apr 2026
9:45am
Market sensitive
Lumos secures new contract manufacturing agreement
Progress Report
02 Apr 2026
12:01pm
Section 708A Cleansing Statement
Cleansing Notice
02 Apr 2026
12:00pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
01 Apr 2026
10:47am
Market sensitive
Lumos receives largest FebriDx order to date
Progress Report
27 Mar 2026
4:33pm
Investor Briefing Invitation
Web Casts
27 Mar 2026
10:13am
Market sensitive
Investor Presentation
Company Presentation
Placement
Security Purchase Plan
27 Mar 2026
10:08am
Market sensitive
US FDA Grants CLIA Waiver for FebriDx
Trading Halt Lifted
Progress Report
27 Mar 2026
10:08am
Proposed issue of securities - LDX
Appendix 3B
27 Mar 2026
10:08am
Market sensitive
Lumos completes $20m placement and launches SPP
Placement
Security Purchase Plan
25 Mar 2026
9:21am
Market sensitive
Trading Halt
Trading Halt
05 Mar 2026
9:34am
Section 708A Cleansing Statement
Cleansing Notice
05 Mar 2026
9:32am
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
03 Mar 2026
10:31am
1H FY26 Results Investor Presentation
Half Yearly Report
Company Presentation
27 Feb 2026
9:49am
Market sensitive
Lumos Delivers Several Pivotal Milestones in 1H FY26
Half Yearly Report
Web Casts
27 Feb 2026
9:47am
Market sensitive
Appendix 4D and Half Year Report
Half Yearly Report
Half Year Audit Review
Half Year Directors' Statement
Half Year Accounts
Half Year Directors' Report
23 Feb 2026
9:45am
Market sensitive
Lumos Completes Enrolment Milestone for Paediatric Study
Progress Report
06 Feb 2026
9:06am
Section 708A Cleansing Statement
Cleansing Notice
06 Feb 2026
9:03am
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
03 Feb 2026
9:27am
Q2 FY26 Results Investor Presentation
Company Presentation
Commitments Test Entity - Second Quarter Activity Report
29 Jan 2026
2:22pm
Market sensitive
Quarterly Activities/Appendix 4C Cash Flow Report
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
19 Jan 2026
10:48am
Lumos secures follow on contract with Aptatek
Progress Report
09 Jan 2026
5:01pm
Section 708A Cleansing Statement
Cleansing Notice
09 Jan 2026
4:58pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
07 Jan 2026
12:20pm
Investor Webinar Invitation-Reducing Diagnostic Uncertainty
Web Casts
2025
18 Dec 2025
12:07pm
Lumos Secures Distribution for FebriDx in Baltic Region
Progress Report
21 Nov 2025
1:22pm
Section 708A Cleansing Statement
Cleansing Notice
21 Nov 2025
1:20pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
21 Nov 2025
1:17pm
Market sensitive
Lumos Secures 100% US Medicare Reimbursement for FebriDx
Progress Report
20 Nov 2025
8:30am
Lumos Enters Strategic Collaboration with AcuityMD
Progress Report
12 Nov 2025
3:29pm
Notification regarding unquoted securities - LDX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
31 Oct 2025
4:34pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
31 Oct 2025
4:31pm
Change of Director's Interest Notice - DW
Change of Director's Interest Notice
31 Oct 2025
4:26pm
Notification regarding unquoted securities - LDX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
28 Oct 2025
4:32pm
New Constitution
Constitution
24 Oct 2025
12:49pm
Results of Annual General Meeting
Results of Meeting
24 Oct 2025
8:56am
2025 AGM Presentation
Company Presentation
Chairman's Address to Shareholders
24 Oct 2025
8:51am
AGM Chair Address
Chairman's Address to Shareholders
23 Oct 2025
8:34am
Market sensitive
Quarterly Activities/Appendix 4C Cash Flow Report
Notice of Meeting - Other
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
22 Oct 2025
9:35am
Lumos Commences FebriDx CLIA Waiver Pediatric Study
Progress Report
16 Oct 2025
9:34am
Lumos Agreement with WellStreet Urgent Care for FebriDx
Progress Report
13 Oct 2025
10:36am
Addendum to Notice of Annual General Meeting
Notice of Meeting - Other
24 Sep 2025
3:31pm
FebriDx UK Data Shows Reduced Antibiotic Use & Cost Savings
Progress Report
24 Sep 2025
11:25am
ASX SMIDcaps 2025 Conference Presentation
Company Presentation
19 Sep 2025
3:58pm
Notice of Annual General Meeting and Proxy Form
Notice of Annual General Meeting
Proxy Form
15 Sep 2025
3:25pm
Section 708A Cleansing Statement
Cleansing Notice
15 Sep 2025
3:23pm
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
11 Sep 2025
9:52am
Section 708A Cleansing Statement
Cleansing Notice
11 Sep 2025
9:50am
Application for quotation of securities - LDX
Appendix 2A (Application for Quotation of Securities
09 Sep 2025
2:53pm
Lumos Signs Second ANZ FebriDx Distribution Agreement
Progress Report
09 Sep 2025
2:10pm
Lumos Completes A$5.0 million Loan Facility
Debt Facility
08 Sep 2025
4:25pm
Notification regarding unquoted securities - LDX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Showing 1–15 of 106 announcements